Journey Medical (DERM) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $15.00 from $12.00 | Aug 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 | Mar 26, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $13.00 | Aug 25, 2025 |
| Lake Street | Maintained | Buy | $13.00 from $9.00 | Aug 13, 2025 |
| B. Riley Securities | Maintained | Buy | $12.00 from $9.00 | Jul 30, 2025 |
| Lake Street | Initiated Coverage | Buy | $9.00 | Sep 6, 2024 |
| Rodman & Renshaw | Initiated Coverage | Buy | $9.00 | Aug 22, 2024 |
| Roth MKM | Maintained | Buy | $11.00 | Jun 28, 2024 |
| Alliance Global Partners | Initiated Coverage | Buy | $8.50 | Feb 16, 2024 |
| B. Riley Securities | Maintained | Buy | $6.00 | Sep 7, 2023 |
| B. Riley Securities | Maintained | Buy | $6.00 from $3.00 | Jul 12, 2023 |
| B. Riley Securities | Maintained | Buy | $3.00 from $6.00 | May 23, 2023 |
Frequently asked questions
Is DERM a buy, sell, or hold?
Analysts covering Journey Medical currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on DERM?
On Aug 13, 2026, B. Riley Securities maintained Journey Medical at Buy with a price target of $15.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.